End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | 31.25M | Sales 2025 * | 25M | Capitalization | 523M |
---|---|---|---|---|---|
Net income 2024 * | -59M | Net income 2025 * | -142M | EV / Sales 2024 * | 14.7 x |
Net cash position 2024 * | 63.88M | Net cash position 2025 * | 257M | EV / Sales 2025 * | 10.7 x |
P/E ratio 2024 * |
-8.77
x | P/E ratio 2025 * |
-5.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.22% |
Latest transcript on Altimmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 18-11-29 |
Director of Finance/CFO | 66 | 21-12-30 | |
Anthony Blandin
CMP | Compliance Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 10-03-31 |
Mack Gill
BRD | Director/Board Member | 72 | 04-07-31 |
Philip Hodges
BRD | Director/Board Member | 56 | 03-08-31 |
1st Jan change | Capi. | |
---|---|---|
+18.21% | 123B | |
+15.00% | 107B | |
-4.12% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.01% | 16.23B | |
+2.80% | 13.43B | |
+26.78% | 11.32B |